Back
Ligand Pharmaceuticals Vs. Evolution AB Industry Stock Comparison
Sell
48
LGND
Ligand Pharmaceuticals
Last Price:
$113.45
Seasonality Move:
9.17%
Sell
28
EVVTY
Evolution AB
Last Price:
$75.37
Seasonality Move:
18.13%
Sell
48
Ligand Pharmaceuticals (LGND)
is a Sell
Is Ligand Pharmaceuticals a Buy, Sell or Hold?
-
The current Ligand Pharmaceuticals [LGND] share price is $113.80. The Score for LGND is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
LGND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Evolution AB (EVVTY)
is a Sell
Is Evolution AB a Buy, Sell or Hold?
-
The current Evolution AB [EVVTY] share price is $75.03. The Score for EVVTY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
EVVTY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LGND Stock Price Chart
What is Ligand Pharmaceuticals's stock price today?
-
The Ligand Pharmaceuticals share price today is $113.80Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LGND is experiencing selling pressure, which indicates risk of future bearish movement.
EVVTY Stock Price Chart
What is Evolution AB's stock price today?
-
The Evolution AB share price today is $75.03Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVVTY is experiencing buying pressure, which is a positive indicator for future bullish movement.
LGND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.24 | Sell |
Relative Strength Index (14 RSI): | 45.5 | Sell |
Chaikin Money Flow: | -76253 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (114.14 - 122.4) | Sell |
Bollinger Bands (100): | (100.52 - 116.88) | Buy |
EVVTY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.92 | Sell |
Relative Strength Index (14 RSI): | 20.42 | Sell |
Chaikin Money Flow: | 290590 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (82.88 - 90.28) | Sell |
Bollinger Bands (100): | (88.01 - 99.79) | Sell |
LGND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 116.23 | Sell |
20-day SMA: | 119.3 | Sell |
50-day SMA: | 115.23 | Sell |
200-day SMA: | 95.57 | Buy |
8-day EMA: | 116.1 | Sell |
20-day EMA: | 117.33 | Sell |
50-day EMA: | 114.73 | Sell |
200-day EMA: | 99.09 | Buy |
EVVTY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 82.07 | Sell |
20-day SMA: | 85.83 | Sell |
50-day SMA: | 89.59 | Sell |
200-day SMA: | 103.12 | Sell |
8-day EMA: | 81.64 | Sell |
20-day EMA: | 84.94 | Sell |
50-day EMA: | 89 | Sell |
200-day EMA: | 99.54 | Sell |
Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.48 per share.
Evolution AB Earnings Growth & EVVTY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ligand Pharmaceuticals Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Evolution AB Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |